S

Surmodics

Supplies IVD reagents and device coatings

Human Resources Generalist

Full-TimePosted on 10/20/2026
No salary listed
Mid
Bachelor's
Horsham, PA, USA
In Person
People & HRGeneralist Recruiting, HR Generalist & Employee Relations

About the job

Requirements
  • At least 3 years of progressive human resources experience, including supporting multiple business functions and managing a range of HR activities.
  • A bachelor's degree in human resources, business administration, or a related field.
  • Demonstrated experience in recruitment and talent acquisition, including partnering with hiring managers and managing multiple open positions.
  • Experience developing, coordinating, or managing HR programs and initiatives.
  • Strong understanding of human resources practices, employee relations, performance management, and applicable employment laws and regulations.
  • Critical-thinking, analytical, problem-solving, and decision-making abilities to assess situations and recommend practical solutions.
  • Written, verbal, interpersonal, and relationship-building skills to communicate effectively across all levels of an organization.
  • Ability to manage competing priorities, independently develop project plans, and drive initiatives through successful execution.
  • Proficiency with Microsoft Office applications, including Excel, Word, and PowerPoint, and ability to work effectively with HR information systems and recruiting technology.
  • Ability to handle confidential and sensitive matters with discretion, professionalism, and sound judgment.
  • A proactive, collaborative, and service-oriented approach, with ability to build credibility and influence stakeholders across the organization.
Responsibilities
  • Lead US recruitment efforts across the organization, partnering with hiring managers to define staffing needs, develop recruitment strategies, establish hiring priorities, and deliver effective hiring outcomes.
  • Manage the full-cycle recruitment process, including job postings, candidate sourcing, screening, interview coordination, candidate assessment, offer management, and onboarding partnership.
  • Build and maintain relationships with external recruiters, staffing partners, universities, and other talent sources to strengthen recruitment pipelines and support business growth.
  • Monitor recruitment metrics and prepare hiring activity reports to evaluate recruiting effectiveness, identify trends, and recommend process improvements.
  • Develop, launch, and manage a company-wide US internship program, including program design, stakeholder engagement, intern recruitment, university partnerships, onboarding, and ongoing program evaluation.
  • Partner with business leaders to identify meaningful internship opportunities, establish program objectives, and create a positive, development-focused experience for interns and participating teams.
  • Provide guidance and support to managers and employees on employee relations matters, performance concerns, workplace policies, and appropriate resolution strategies.
  • Lead or coordinate thorough, objective, and confidential employee investigations, document findings, and recommend appropriate actions in partnership with relevant stakeholders.
  • Provide guidance, training, and interpretation of HR policies, procedures, and practices to promote consistency and effective application across the organization.
  • Serve as the primary HR site contact for the Horsham, Pennsylvania office, supporting local employee needs, coordinating site-related HR activities, facilitating employee engagement initiatives, and promoting a positive and connected workplace experience.
  • Support site communications, employee events, office-related initiatives, and coordination with internal stakeholders to keep the Horsham office aligned with broader organizational priorities.
  • Partner with business leaders and functional stakeholders to develop and implement HR strategies and initiatives that support organizational priorities, strengthen company culture, and enhance employee engagement.
  • Facilitate organizational planning processes, including workforce planning, organizational structure assessments, and identification of talent needs and capability gaps.
  • Support talent management initiatives, including performance management, leadership development, succession planning, and employee development.
  • Contribute to the development and implementation of compensation strategies and programs that support business objectives and promote internal equity and external competitiveness.
  • Identify opportunities to improve HR processes, programs, and practices to enhance organizational effectiveness and the overall employee experience.
  • Maintain current knowledge of applicable federal, state, and local employment laws and regulations and support compliance across the US.
  • Partner with Legal and other relevant stakeholders on employment-related matters, policy interpretation, investigations, and risk mitigation as needed.
  • Maintain accurate employee records, HR documentation, and HR information systems in accordance with company policies and applicable legal requirements.
  • Support the development, communication, implementation, and ongoing review of HR policies, procedures, and programs.
  • Maintain appropriate confidentiality and ensure accurate handling of sensitive employee and organizational information.
  • Support HR reporting, documentation, and administrative processes to promote operational efficiency and data integrity.
Desired Qualifications
  • Experience establishing an internship or early-career talent program.

About the company

Surmodics provides components for in vitro diagnostics (IVD) and coatings for medical devices. Its IVD products include ELISA reagents, antigens, antibodies, and microarray slides that support sensitive immunoassays used to detect substances in samples, while its coatings include lubricious, hemocompatible, and drug-delivery options for devices like stents. The company differentiates itself by combining reagent supply with active collaboration on coating development and by offering design and production services for advanced balloon catheters, helping projects move to market faster. Its goal is to help customers bring diagnostic tests and coated medical devices to market efficiently.

Company Size

201-500

Company Stage

IPO

Headquarters

Eden Prairie, Minnesota

Founded

1979

Get referred to Surmodics

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The October 1, 2026 Alta Biomed acquisition deepens hemocompatible coatings and blood-testing capabilities.
  • Surmodics launched Galway contract coating services on September 23, 2026, expanding European demand access.
  • Pounce XL reached commercial release in April 2025, proving Surmodics can still launch devices.

What critics are saying

  • GTCR’s ownership and Biocoat overlap keep Surmodics exposed to antitrust scrutiny and customer skepticism.
  • Endologix bought Pounce on May 18, 2026, shrinking Surmodics’ device pipeline and revenue mix.
  • If a major coatings customer shifts to Integer or Teleflex, Surmodics loses scale fast.

What makes Surmodics unique

  • Surmodics pairs hydrophilic coatings, hemocompatible surfaces, and analytical testing under one platform.
  • Alta Biomed’s PzF technology adds anti-thrombotic surface options and West Coast testing.
  • Ballinasloe and Carlsbad sites place coating engineering closer to European and Californian customers.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Performance Bonus
  • 401(k) Company Match
  • 401(k) Retirement Plan
  • Company Equity
  • Stock Options

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

5%

2 year growth

5%
Associated Press
Oct 7th, 2026
Surmodics opens IOL cartridge coating automation center in Pennsylvania

Surmodics has launched an IOL Cartridge Coating Automation Center at its Horsham, Pennsylvania facility. The centre combines hydrophilic coating technology with automated processing for intraocular lens delivery systems. The facility offers HydroBond 5/5, a hyaluronic acid-based coating designed for IOL cartridges, with cure times under five minutes per layer to support high-throughput production. The coating creates lubricious cartridge surfaces for smooth lens delivery. Surmodics will provide customised solutions ranging from coating automation integration into existing operations to fully outsourced manufacturing programmes. The company has partnered with injection moulders and automation equipment suppliers to support flexible manufacturing models. The centre aims to help ophthalmic device manufacturers achieve scalable production from initial feasibility through commercial-scale manufacturing. Surmodics brings nearly 50 years of surface technology experience, including over 20 years specifically in IOL cartridge coating.

Health Technology Net
Oct 7th, 2026
Surmodics launches IOL Cartridge Coating Automation Center in Horsham.

Surmodics launches IOL Cartridge Coating Automation Center in Horsham. New center combines advanced hydrophilic coating technology, IOL cartridge application expertise and automated processing to support scalable ophthalmic device manufacturing Learn Engineering HORSHAM, PA / ACCESS Newswire / October 7, 2026 / Surmodics, a provider of surface technologies and performance coatings for the medical device industry, today announced at the opening of the American Academy of Ophthalmology annual meeting in New Orleans the launch of its IOL Cartridge Coating Automation Center at its Horsham, Pennsylvania site just outside Philadelphia. "The delivery system for an intraocular lens (IOL) combines precision injection-molded parts with a specifically selected lubricious, biofriendly coating," said Chip Hance, CEO of Surmodics. "As IOL manufacturers increasingly seek automated assembly and modern biomaterial formulations, our Automation Center provides automated coating processes designed for efficient production throughout the product lifecycle." The center brings together advanced hydrophilic coating technology, decades of IOL cartridge application expertise, precision coatings processes and automation capabilities in a manufacturing platform developed specifically for IOL delivery cartridges. Its modernized process aligns application and curing with cartridge geometry and automated manufacturing requirements, supporting consistent coating of critical internal surfaces while reducing process time and reliance on manual manufacturing steps. Discover more Get Health Tips A key technology available through the center is HydroBond(TM) 5/5, a proven hyaluronic acid-based hydrophilic coating engineered for IOL cartridge applications. The coating and associated rapid thermal cure process are designed to enable base coat and topcoat cure times of less than five minutes each, creating a process architecture well suited for automated, high-throughput production. The coating provides a highly lubricious cartridge surface designed to facilitate smooth lens passage through the delivery system. Having developed relationships with experienced injection molders and automation equipment partners, Surmodics can develop customized solutions ranging from integration of coating automation into customers' existing manufacturing operations to fully outsourced cartridge coating and manufacturing programs. This flexible approach enables customers to select a manufacturing model aligned with their product, volume and commercialization requirements. "For ophthalmic device manufacturers, consistent cartridge performance requires efficient, scalable manufacturing," said Bob Hergenrother, VP of R&D and Innovation at Surmodics. "Our center combines coating chemistry, cartridge expertise and automation to support customers from initial feasibility through process optimization and commercial-scale production." About Surmodics Surmodics provides performance coatings, specialty hydrogels and pigments, drug delivery capabilities and analytical testing to leading ophthalmology companies. With nearly 50 years of experience in surface technology and biomaterials, including more than 20 years of IOL cartridge coating experience, Surmodics supports medical device developers from early-stage feasibility through commercialization with expertise in surface modification, application development and process optimization. For more information, visit www.surmodics.com.

Newswire
Oct 1st, 2026
Surmodics acquires Alta Biomed business, expanding hemocompatible surface technology and analytical testing capabilities.

Surmodics acquires Alta Biomed business, expanding hemocompatible surface technology and analytical testing capabilities. Acquisition adds proven PzF(TM) thin-film surface modification technology, specialized blood- and tissue-contacting device expertise and a West Coast testing facility HORSHAM, Pa., October 1, 2026 (Newswire.com) - Surmodics Inc., a leading provider of surface technologies and performance coatings for the medical device industry, today announced that it has acquired the business of Alta Biomed, a Carlsbad, California-based medical device coating and testing services company specializing in surface technologies for vascular and other medical devices. The acquisition is a strategic addition to Surmodics' growing portfolio of hemocompatible and biocompatible surface technologies. It brings Alta Biomed's proprietary PzF(TM) thin-film surface modification technology to Surmodics, adding an established anti-thrombotic, anti-inflammatory and pro-healing option that joins Surmodics' existing hemocompatible portfolio. "As medical device innovation advances in neuromodulation, brain-computer interfaces, neurovascular, structural heart, and venous and arterial technologies, engineers and scientists need a broader range of surface technology options to address increasingly complex blood-contacting applications," said Charlie Olson, President, Surmodics Coatings, Biomaterials and Catheter Technologies. "PzF gives our customers another proven thin-film surface modification to consider as they develop the next generation of devices." PzF is an ultra-thin polymer surface modification technology designed to enhance hemocompatibility for blood and tissue-contacting medical devices and materials. With more than 20 years of history in medical device applications, PzF has received six FDA clearances and one PMA approval and is commercialized today in cardiovascular and embolization technologies. The technology can be applied to a variety of substrates ranging from metals, polymers, medical fabrics and even tissue. Device applications include stents, grafts, catheters, filters, nitinol devices, ePTFE devices and PET/polyester materials. The acquisition also expands Surmodics' analytical testing capabilities. Alta Biomed's Carlsbad facility brings established expertise in hemocompatibility and particulate testing, including coating integrity assessment, acute particulate testing and dynamic human blood loop testing used to compare coated and uncoated devices. With the acquisition complete, Surmodics has assumed Alta Biomed's ongoing operations in Carlsbad. The location expands Surmodics' geographic footprint and provides a West Coast presence closer to many medical device companies in California and the surrounding region. Existing Alta Biomed programs will continue as the company's PzF surface modification and testing capabilities are integrated into the broader Surmodics organization. "This acquisition is a natural and exciting next step for our team. Joining Surmodics provides the scale, established leadership and global access to reach more patients with our advanced coating technologies," said Chris Nocera, VP of Engineering, Alta Biomed, who will lead the Carlsbad site. The acquisition further advances Surmodics' strategy to build a differentiated portfolio of coating and surface modification technologies, specialty biomaterials and technical services that can support medical device companies from early feasibility and technology selection through testing, process development and commercialization. About Alta Biomed Alta Biomed, formerly Alta Biomaterials and a portfolio company of Nidus Biomedical, is a medical device coating services and testing company based in Carlsbad, California. The company specializes in PzF thin-film surface technology for vascular and other medical devices and works with medical device developers on coating feasibility, process development, coating integrity assessment, particulate testing and dynamic human blood loop testing. For more information visit www.altabiomed.com/. About Surmodics Surmodics provides performance coatings, surface technologies, specialty polymers, analytical testing, drug delivery and catheter development capabilities to the medical device industry. With nearly 50 years of experience in surface technology and biomaterials, Surmodics works with medical device developers to improve device performance and support programs from early-stage feasibility through commercialization. For more information, visit www.surmodics.com. Media Contact

Associated Press
Sep 10th, 2026
Surmodics expands medical device coating capabilities to Ireland's MedTech hub

Surmodics has expanded its medical device coating capabilities in Galway, Ireland, establishing dedicated cleanroom environments for coating services. The facility brings the company's nearly 50 years of coating expertise closer to medical device manufacturers across Ireland and Europe. The Ireland site offers coating feasibility, process development, coating services, and analytical testing. Surmodics' coating portfolio includes hydrophilic, hemocompatible, antimicrobial, and drug delivery technologies for medical devices. "Ireland is home to a significant concentration of medical device manufacturers and technology innovators," said Damien Kilcommons, vice president of site operation at the Ireland facility. The expansion strengthens Surmodics' ability to support medical device companies from early-stage development through commercialisation. The move forms part of Surmodics' broader strategy to strengthen its focus on coatings and biomaterials whilst expanding global access to its capabilities.

Orange County Business Journal
May 19th, 2026
Endologix acquires Pounce System from Surmodics.

Endologix acquires Pounce System from Surmodics. Adds FDA-cleared device to vascular intervention portfolio Yuika Yoshida May 19, 2026 Irvine medical device maker Endologix today announced its acquisition of the Pounce Thrombectomy System from Minnesota-based Surmodics Inc. The Pounce System is an FDA-cleared device for the non-surgical removal of thrombi and emboli from peripheral arteries. "The Pounce Thrombectomy System is a strong strategic and clinical fit for Endologix," John Liddicoat, chief executive and president of Endologix, said in a statement. The acquisition expands Endologix' commercial offerings, which include its Detour, Alto and AFX2 platforms. Want more from the best local business newspaper in the country? Sign-up for its FREE Daily eNews update to get the latest Orange County news delivered right to your inbox! One-Year for Only $99 * Unlimited access to OCBJ.com * Daily OCBJ Updates delivered via email each weekday morning * Journal issues in both print and digital format * The annual Book of Lists: industry of Orange County's leading companies * Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!